Literature DB >> 9310111

Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome.

B Regland1, M Andersson, L Abrahamsson, J Bagby, L E Dyrehag, C G Gottfries.   

Abstract

Twelve outpatients, all women, who fulfilled the criteria for both fibromyalgia and chronic fatigue syndrome were rated on 15 items of the Comprehensive Psychopathological Rating Scale (CPRS-15). These items were chosen to constitute a proper neurasthenic subscale. Blood laboratory levels were generally normal. The most obvious finding was that, in all the patients, the homocysteine (HCY) levels were increased in the cerebrospinal fluid (CSF). There was a significant positive correlation between CSF-HCY levels and fatiguability, and the levels of CSF-B12 correlated significantly with the item of fatiguability and with CPRS-15. The correlations between vitamin B12 and clinical variables of the CPRS-scale in this study indicate that low CSF-B12 values are of clinical importance. Vitamin B12 deficiency causes a deficient remethylation of HCY and is therefore probably contributing to the increased homocysteine levels found in our patient group. We conclude that increased homocysteine levels in the central nervous system characterize patients fulfilling the criteria for both fibromyalgia and chronic fatigue syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310111     DOI: 10.3109/03009749709105320

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  15 in total

1.  Vitamin B status in patients with chronic fatigue syndrome.

Authors:  L C Heap; T J Peters; S Wessely
Journal:  J R Soc Med       Date:  1999-04       Impact factor: 5.344

2.  Serum levels of vitamin B12 (cobalamin) in fibromyalgia.

Authors:  Jozélio Freire de Carvalho; Daisy Naiana Freitas Silva
Journal:  Rheumatol Int       Date:  2016-03-14       Impact factor: 2.631

Review 3.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

Review 4.  Brain imaging in fibromyalgia.

Authors:  Liliana Lourenço Jorge; Edson Amaro
Journal:  Curr Pain Headache Rep       Date:  2012-10

5.  Curcumin has neuroprotection effect on homocysteine rat model of Parkinson.

Authors:  Zahra Mansouri; Masoumeh Sabetkasaei; Fatemeh Moradi; Fatemeh Masoudnia; Amin Ataie
Journal:  J Mol Neurosci       Date:  2012-03-15       Impact factor: 3.444

Review 6.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

7.  A Brief Historic Overview of Clinical Disorders Associated with Tryptophan: The Relevance to Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).

Authors:  Adele Blankfield
Journal:  Int J Tryptophan Res       Date:  2012-09-17

8.  Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia.

Authors:  Björn Regland; Sara Forsmark; Lena Halaouate; Michael Matousek; Birgitta Peilot; Olof Zachrisson; Carl-Gerhard Gottfries
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

9.  Kynurenine Pathway Pathologies: do Nicotinamide and Other Pathway Co-Factors have a Therapeutic Role in Reduction of Symptom Severity, Including Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).

Authors:  Adele Blankfield
Journal:  Int J Tryptophan Res       Date:  2013-07-21

10.  Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).

Authors:  Gerwyn Morris; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.